Fmr LLC Alkermes Plc. Put Options Transaction History
Fmr LLC
- $1.68 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
391Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$930 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$591 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$321 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$262 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$205 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.25B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...